Microfabrication for Drug Delivery

被引:23
作者
Koch, Brendan [1 ]
Rubino, Ilaria [1 ]
Quan, Fu-Shi [2 ]
Yoo, Bongyoung [3 ]
Choi, Hyo-Jick [1 ]
机构
[1] Univ Alberta, Dept Chem & Mat Engn, Edmonton, AB T6G 1H9, Canada
[2] Kyung Hee Univ, Dept Med Zool, Sch Med, Seoul 130701, South Korea
[3] Hanyang Univ, Dept Mat Sci & Chem Engn, Ansan 426791, Gyeonggi Do, South Korea
基金
新加坡国家研究基金会;
关键词
microfabrication; drug delivery; biocompatibility; TRANSDERMAL DELIVERY; MICRONEEDLE PATCHES; IN-VIVO; CONTROLLED-RELEASE; ORAL DELIVERY; DISSOLVING MICRONEEDLES; 2-PHOTON POLYMERIZATION; TARGETED DELIVERY; IMMUNE-RESPONSES; INSULIN DELIVERY;
D O I
10.3390/ma9080646
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
This review is devoted to discussing the application of microfabrication technologies to target challenges encountered in life processes by the development of drug delivery systems. Recently, microfabrication has been largely applied to solve health and pharmaceutical science issues. In particular, fabrication methods along with compatible materials have been successfully designed to produce multifunctional, highly effective drug delivery systems. Microfabrication offers unique tools that can tackle problems in this field, such as ease of mass production with high quality control and low cost, complexity of architecture design and a broad range of materials. Presented is an overview of silicon-and polymer-based fabrication methods that are key in the production of microfabricated drug delivery systems. Moreover, the efforts focused on studying the biocompatibility of materials used in microfabrication are analyzed. Finally, this review discusses representative ways microfabrication has been employed to develop systems delivering drugs through the transdermal and oral route, and to improve drug eluting implants. Additionally, microfabricated vaccine delivery systems are presented due to the great impact they can have in obtaining a cold chain-free vaccine, with long-term stability. Microfabrication will continue to offer new, alternative solutions for the development of smart, advanced drug delivery systems.
引用
收藏
页数:36
相关论文
共 208 条
[1]  
3M, 3M HOLL MICR TRANSD
[2]  
3M, 3M SOL MICR TRANSD S
[3]  
ABELIN T, 1989, LANCET, V1, P7
[4]   Clinical Coronary In-Stent Restenosis Follow-Up after Treatment and Analyses of Clinical Outcomes [J].
Abreu Marino, Barbara Campos ;
Nascimento, Guilherme Abreu ;
Rabelo, Walter ;
Marino, Marcos Antonio ;
Marino, Roberto Luiz ;
Pinho Ribeiro, Antonio Luiz .
ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2015, 104 (05) :375-386
[5]   Biological responses to materials [J].
Anderson, JM .
ANNUAL REVIEW OF MATERIALS RESEARCH, 2001, 31 :81-110
[6]   Characterization of surface-modified nanoparticles for in vivo biointeraction. A sedimentation field flow fractionation study [J].
Andersson, M ;
Fromell, K ;
Gullberg, E ;
Artursson, P ;
Caldwell, KD .
ANALYTICAL CHEMISTRY, 2005, 77 (17) :5488-5493
[7]  
[Anonymous], 2015, 10993 ISO FDA 1
[8]  
[Anonymous], 2009, 1099312009 ISO
[9]   Intradermal influenza vaccine and new devices: a promising chance for vaccine improvement [J].
Ansaldi, Filippo ;
Durando, Paolo ;
Icardi, Giancarlo .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2011, 11 (03) :415-427
[10]  
Attwood D., 2012, Surfactant Systems: Their chemistry, pharmacy and biology